BOLD Stock Analysis: Buy, Sell, or Hold?
BOLD - Boundless Bio, Inc. Common Stock
$2.60
1.20 (85.71%)
▲
5d:
+85.71%
30d:
+79.31%
90d:
+126.09%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When BOLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: BOLD is 52.9% above its trading range ($1.70). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: BOLD is 52.9% above its trading range ($1.70). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: BOLD is currently trading at $2.60, which is considered extended relative to its 30-day fair value range of $1.25 to $1.70.
Technical Outlook: Technically, BOLD is in a uptrend. Immediate support is located at $1.38, while resistance sits at $2.75. The stock is showing strong short-term momentum, up 85.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+53.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BOLD is in a uptrend. Immediate support is located at $1.38, while resistance sits at $2.75. The stock is showing strong short-term momentum, up 85.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+53.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.25 -
$1.70
Company Quality Score
59/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+52.9% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+85.7%)
- BULLISH: Trading 53.8% below Wall St target ($4.00)
Trading Range Analysis
30-Day Trading Range
$1.25 -
$1.70
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.38
Resistance Level
$2.75
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.03
Wall Street Target
$4.00
(+53.8%)
Share & Embed Analysis
Last updated: June 24, 2026 5:09 AM ET
Data refreshes hourly during market hours. Next update: 6:09 AM
Data refreshes hourly during market hours. Next update: 6:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$8 | 60 HOLD |
